A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
TV veteran Sir Bruce Forsyth has died at the age of 89
Police say two were killed and a further six wounded after the attack in western Finland.
Longer spells of rain across eastern Scotland with a weather warning in place until 6pm.